tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate oxalate

Catalog No.: 
ACLUDK594
CAS No.: 
1180112-42-8
Molecular Formula: 
C14H24N2O6
Molecular Weight: 
316.35
tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate oxalate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$242.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate oxalate
IUPAC Nametert-butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate oxalate
MDL No.MFCD13185087
Molecular FormulaC14H24N2O6
Molecular Weight316.35
SMILESO=C(N(CC1)CCC21CCN2)OC(C)(C)C.O=C(O)C(O)=O
InChI KeyHLBLCLWSYNFUSK-UHFFFAOYSA-N
Synonym1180112-42-8 | tert-Butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate oxalate | 7-Boc-1,7-diaza-spiro[3.5]nonane oxalate | tert-butyl 1,7-diazaspiro[3.5]nonane-7-carboxylate;oxalic acid | 7-Boc-1,7-diaza-spiro[3.5]nonane hemioxalate | 1,7-Diazaspiro[3.5]nonane-7-carbox
CAS No.1180112-42-8
PubChem CID86811246

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACLUDK594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUDK594 route product structure diagram
    ACLUDK5941180112-42-8
Inquiry

2. ACLUDK594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUDK594 route product structure diagram
    ACLUDK5941180112-42-8
Inquiry

3. ACLUDK594 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLUDK594 route product structure diagram
    ACLUDK5941180112-42-8
Inquiry

Comments (0)